Fundz
New|Fundz now works inside Claude2 min

Signals were just the beginning. Fundz is what’s next.

Only Fundz brings more than a dozen live business signals together on each company, ranks every company against your ICP, and each morning delivers the best: who to reach out to, why, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Spark Biomedical Appoints Ric Peterson as Chief Financial Officer and Tom Futch as Executive Vice President of Growth

PRIVATEOct 08, 2026
New to company · from Medicis Pharmaceutical“As EVP, CFO and Treasurer of Medicis Pharmaceutical, he guided the company from private to public markets, through growth, and through its sale. A former PricewaterhouseCoopers professional and director of Universal Insurance Holdings, Inc., Peterson will put in place Spark's financial and governance systems for its next phase of growth.”

Position

Executive Vice President

Company

Spark Biomedical

Tom Futch
DallasHealth Care

Description

Spark Biomedical announces the addition of three industry veterans to their leadership team, aimed at advancing the company's strategic priorities. Ric Peterson is the new Chief Financial Officer, while Tom Futch joins as Executive Vice President of Growth, and Jeff Jones is appointed Executive Vice President of Manufacturing Operations.

Company Information

Company

Spark Biomedical

Location

18208 PRESTON ROAD, SUITE D9-531

Dallas, Texas, United States

About

Spark Biomedical, Inc. is a leading U.S.-based medical device developer, committed to unlocking the potential of bioelectronic medicine and bringing to market novel wearable neurostimulation treatment options in behavioral health, women's health, hemostasis, pediatrics, and chronic pain. Spark leverages its neuroscience and engineering expertise to empower healthcare providers and researchers with innovative, evidence-based tools designed to address complex care situations which exceed the capabilities of existing treatment options. Spark has received funding from federal institutions, such as the NIH and DoD, and continues to partner with private and academic institutions. Spark Biomedical is empowering a better way forward for the future of patient care and medical technology.

Fundz sees it the moment Spark Biomedical changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Daniel
Likely contact at this company
••••••••@••••••••

See Daniel's verified email →

Ric
Likely contact at this company
••••••••@••••••••

See Ric's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Spark Biomedical's next move

Learn about Strategic plan

Spark Biomedical changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.